Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis

Serum miRNAs have gained great popularity to act as circulating biomarkers of several cancers. In this study, we aimed to evaluate the diagnostic efficiency of serum miR-21 as novel biomarkers for patients with hepatocellular carcinoma (HCC) and other controls. A total of 533 individuals were recrui...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xin, Lv, Xiaohui, Lv, Xing, Ma, Yueyun, Chen, Lin, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546461/
https://www.ncbi.nlm.nih.gov/pubmed/28477010
http://dx.doi.org/10.18632/oncotarget.17211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546461/
https://www.ncbi.nlm.nih.gov/pubmed/28477010
http://dx.doi.org/10.18632/oncotarget.17211

Ejemplares similares